Neutropenia News and Research

RSS
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood.
FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

FDA approves new maintenance therapy for recurrent cancers

FDA approves new maintenance therapy for recurrent cancers

FDA approves new drug to treat adults with moderate-to-severe plaque psoriasis

FDA approves new drug to treat adults with moderate-to-severe plaque psoriasis

FDA approves new therapy for initial treatment of soft tissue sarcoma

FDA approves new therapy for initial treatment of soft tissue sarcoma

Long-term clinical data, experience supports effectiveness of PRRT for treating neuroendocrine tumors

Long-term clinical data, experience supports effectiveness of PRRT for treating neuroendocrine tumors

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

BCL-2 inhibitor shows promise in AML patients

BCL-2 inhibitor shows promise in AML patients

Researchers identify specific pathways involved in development of mucormycosis

Researchers identify specific pathways involved in development of mucormycosis

Clinical trial to evaluate safety of palbociclib drug in African American women with breast cancer

Clinical trial to evaluate safety of palbociclib drug in African American women with breast cancer

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

New IDSA guidelines focus on diagnosis, treatment of deadly aspergillosis

New IDSA guidelines focus on diagnosis, treatment of deadly aspergillosis

Salvage inotuzumab ozogamicin improves ALL outcomes

Salvage inotuzumab ozogamicin improves ALL outcomes

Long-term dasatinib findings support first-line use in CML

Long-term dasatinib findings support first-line use in CML

New drug ixekizumab helps clear severe psoriasis symptoms

New drug ixekizumab helps clear severe psoriasis symptoms

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Combination therapy equally good at treating small cell lung cancer

Combination therapy equally good at treating small cell lung cancer

EPIC Results Shed Light On First-Line Ponatinib Risk-Benefit Profile

EPIC Results Shed Light On First-Line Ponatinib Risk-Benefit Profile